Wu Lei, Wang Tongfei, Jiang Siyuan, Zhang Juan, Zhang Mi, Gao Huan, Wang Hui, Zhou Yan, Ran Ran, Dong Danfeng, Yang Jin
Department of Medical Oncology, Xi 'an No.3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, China.
Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Front Oncol. 2025 May 22;15:1515893. doi: 10.3389/fonc.2025.1515893. eCollection 2025.
The incidence of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) is increasing. To improve patient outcomes, it is essential to develop integrated treatment strategies based on tumor characteristics. Researchers need a rapid visualization of global research trends in GEP-NETs. However, there is currently no bibliometric analysis of GEP-NETs available. This paper aims to fill this gap by using bibliometric methods to quantitatively visualize the current status and research hotspots of GEP-NETs from 2000 to 2023, thereby providing a reference for future research.
We analyzed 1,140 English publications on GEP-NETs from 2000 to 2023, sourced from the Web of Science Core Collection (WOSCC). Microsoft Excel 2021, CiteSpace, and VOSviewer were used for bibliometric analysis and visualization.
From 2000 to 2023, the number of annual publications on GEP-NETs steadily increased. We identified 1,140 articles published in 401 journals by 5,751 authors from 55 countries. The United States emerged as a leading contributor to GEP-NETs research. Erasmus University Rotterdam, the journal Neuroendocrinology, and the author De Herder WW had the highest number of publications. The most frequently cited reference was by Dasari A. A co-word analysis of keywords revealed five research clusters within the field of GEP-NETs. Immunotherapy and peptide receptor radionuclide therapy (PRRT) are prominent research trends. The terms "carcinoid tumors" and "Lu 177 dotatate" showed significant burst strength.
With the rising incidence of GEP-NETs, there is an increasing focus on their diagnosis and treatment. This bibliometric analysis spotlights the current status, key contributors, top journals, influential publications, and the trends of research topics on GEP-NETs. It provides a comprehensive overview of GEP-NETs research from 2000 to 2023. By providing this quantitative analysis, our study aims to guide future research efforts and support the development of more effective diagnosis and treatment strategies, ultimately advancing the field of GEP-NETs. Our study can help researchers understand global research trends and future directions in GEP-NETs.
胃肠胰神经内分泌肿瘤(GEP-NETs)的发病率正在上升。为改善患者预后,基于肿瘤特征制定综合治疗策略至关重要。研究人员需要快速了解GEP-NETs的全球研究趋势。然而,目前尚无关于GEP-NETs的文献计量分析。本文旨在通过文献计量方法,定量可视化2000年至2023年GEP-NETs的现状和研究热点,从而为未来研究提供参考。
我们分析了2000年至2023年来自科学网核心合集(WOSCC)的1140篇关于GEP-NETs的英文出版物。使用Microsoft Excel 2021、CiteSpace和VOSviewer进行文献计量分析和可视化。
2000年至2023年,GEP-NETs的年度出版物数量稳步增加。我们确定了来自55个国家的5751名作者在401种期刊上发表的1140篇文章。美国成为GEP-NETs研究的主要贡献者。鹿特丹伊拉斯姆斯大学、《神经内分泌学》杂志和作者德赫德·WW的出版物数量最多。被引用次数最多的参考文献是达萨里·A的。对关键词的共词分析揭示了GEP-NETs领域内的五个研究集群。免疫疗法和肽受体放射性核素疗法(PRRT)是突出的研究趋势。“类癌肿瘤”和“镥177奥曲肽”这两个术语显示出显著的突发强度。
随着GEP-NETs发病率的上升,对其诊断和治疗的关注日益增加。这项文献计量分析突出了GEP-NETs的现状、主要贡献者、顶级期刊、有影响力的出版物以及研究主题的趋势。它提供了2000年至2023年GEP-NETs研究的全面概述。通过提供这种定量分析,我们的研究旨在指导未来的研究工作,并支持开发更有效的诊断和治疗策略,最终推动GEP-NETs领域的发展。我们的研究可以帮助研究人员了解GEP-NETs的全球研究趋势和未来方向。